Tg Therapeutics (TGTX) Current Leases: 2019-2025
Historic Current Leases for Tg Therapeutics (TGTX) over the last 7 years, with Sep 2025 value amounting to $1.1 million.
- Tg Therapeutics' Current Leases fell 13.24% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 13.24%. This contributed to the annual value of $1.2 million for FY2024, which is 19.99% down from last year.
- Latest data reveals that Tg Therapeutics reported Current Leases of $1.1 million as of Q3 2025, which was down 2.11% from $1.1 million recorded in Q2 2025.
- Over the past 5 years, Tg Therapeutics' Current Leases peaked at $1.6 million during Q3 2022, and registered a low of $1.1 million during Q3 2025.
- Over the past 3 years, Tg Therapeutics' median Current Leases value was $1.3 million (recorded in 2024), while the average stood at $1.3 million.
- Per our database at Business Quant, Tg Therapeutics' Current Leases increased by 10.08% in 2022 and then dropped by 19.99% in 2024.
- Over the past 5 years, Tg Therapeutics' Current Leases (Quarterly) stood at $1.4 million in 2021, then grew by 10.02% to $1.6 million in 2022, then fell by 8.54% to $1.4 million in 2023, then fell by 19.99% to $1.2 million in 2024, then dropped by 13.24% to $1.1 million in 2025.
- Its Current Leases stands at $1.1 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.1 million for Q1 2025.